Cite
HARVARD Citation
Thayer, S. et al. (n.d.). Real-world evaluation of glycemic control among patients with type 2 diabetes mellitus treated with canagliflozin versus dipeptidyl peptidase-4 inhibitors. Current medical research and opinion. pp. 1087-1096. [Online].